Article Information
- Received February 28, 2001
- Revision received May 16, 2001
- Accepted June 12, 2001
- First published September 1, 2001.
- Version of record published September 1, 2001.
Author Information
- Alberto Bacci1,
- Silvia Coco1,
- Elena Pravettoni1,
- Ursula Schenk1,
- Simona Armano1,
- Carolina Frassoni2,
- Claudia Verderio1,
- Pietro De Camilli3, and
- Michela Matteoli1
- 1Consiglio Nazionale delle Ricerche, Cellular and Molecular Pharmacology and “B. Ceccarelli” Centers, Department of Medical Pharmacology, University of Milan, 20129 Milan, Italy,
- 2Neurological Institute “C. Besta”, 20133 Milan, Italy and
- 3Howard Hughes Medical Institute and Department of Cell Biology, Yale School of Medicine, New Haven, Connecticut 06510
Author contributions
Disclosures
- Received February 28, 2001.
- Revision received May 16, 2001.
- Accepted June 12, 2001.
This work was supported by European Community Grant QLGR3-CT-2000-01343 (coordinator E. Scarfone), by Telethon Italy Grant 1042 (M.M.), and by National Institutes of Health Grant NS 36251 (P.D.C.). We thank Roberto Gramignoli for help in some experiments. We thank Drs. R. Jahn (Gottingen, Germany) and M. Solimena (Yale University) for the generous gift of antibodies. We also thank Prof. C. Montecucco (University of Padova), Prof. F. Clementi (University of Milan), and Prof. F. Valtorta (DIBIT, Milan) for discussion.
A.B. and S.C. contributed equally to this paper.
Correspondence should be addressed to Dr. Michela Matteoli, Consiglio Nazionale delle Ricerche Cellular and Molecular Pharmacology, and “B. Ceccarelli” Centers, Department of Medical Pharmacology, University of Milan, via Vanvitelli 32, 20129 Milan, Italy. E-mail:MichelaM{at}csfic.mi.cnr.it.
A. Bacci's present address: Department of Neurology and Neurological Sciences, Stanford University Medical Center, Stanford, CA 94035.
Online Impact